Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company’s Pioneering Work in Mitochondrial Medicine

B – Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership – – Appointment signals expansion of executive team…
posteditor
posteditor
Articles: 16137

Other News